IRIDEX Corporation (IRIX)

Market Cap	17.12M
Revenue (ttm)	48.67M
Net Income (ttm)	-8.91M
Shares Out	16.79M
EPS (ttm)	-0.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	106,234
Open	1.035
Previous Close	1.030
Day's Range	1.020 - 1.035
52-Week Range	0.780 - 3.290
Beta	0.74
Analysts	Hold
Price Target	2.00 (+96.08%)
Earnings Date	May 13, 2025

About IRIX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx, a laser photocoagulation system that are used to treat proliferative diabetic reti...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 15, 1996
• Employees: 93
• Stock Exchange: NASDAQ
• Ticker Symbol: IRIX
• Website: https://www.iridex.com

Financial Performance

In 2024, IRIDEX's revenue was $48.67 million, a decrease of -6.17% compared to the previous year's $51.87 million. Losses were -$8.91 million, -6.90% less than in 2023.

Analyst Forecast

According to one analyst, the rating for IRIX stock is "Hold" and the 12-month stock price forecast is $2.0.

Price Target

$2.0

(96.08% upside)

Analyst Consensus: Hold